← Back to Search
Genipin-cross-linked Fucose-chitosan/heparin Nanoparticles For The Eradication Of Helicobacter Pylori.
Y. Lin, S. Tsai, C. Lai, Che-Hsin Lee, Zih Sian He, G. Tseng
Published 2013 · Materials Science, Medicine
Download PDFAnalyze on Scholarcy
Helicobacter pylori is a significant human pathogen that recognizes specific carbohydrate receptors, such as the fucose receptor, and produces the vacuolating cytotoxin, which induces inflammatory responses and modulates the cell-cell junction integrity of the gastric epithelium. The clinical applicability of topical antimicrobial agents was needed to complete the eradication of H. pylori in the infected fundal area. In the present study, we combined fucose-conjugated chitosan and genipin-cross-linking technologies in preparing multifunctional genipin-cross-linked fucose-chitosan/heparin nanoparticles to encapsulate amoxicillin of targeting and directly make contact with the region of microorganism on the gastric epithelium. The results show that the nanoparticles effectively reduced drug release at gastric acids and then released amoxicillin in an H. pylori survival situation to inhibit H. pylori growth and reduce disruption of the cell-cell junction protein in areas of H. pylori infection. Furthermore, with amoxicillin-loaded nanoparticles, a more complete H. pylori clearance effect was observed, and H. pylori-associated gastric inflammation in an infected animal model was effectively reduced.
This paper references
Formulation and evaluation of water-in-oil amoxicillin-loaded nanoemulsions using for Helicobacter pylori eradication
Yu-Hsin Lin (2012)
Agglutination of Helicobacter pylori coccoids by lectins.
M. M. Khin (2000)
Receptor Mediated Targeting of Lectin Conjugated Gliadin Nanoparticles in the Treatment of Helicobacter pylori
R. Umamaheshwari (2003)
Local gastric and serum amoxicillin concentrations after different oral application forms.
M. Cooreman (1993)
Intragastric administration of heparin enhances gastric ulcer healing through a nitric oxide-dependent mechanism in rats.
Y. Li (2000)
Monocyte and Macrophage Killing of Helicobacter pylori: Relationship to Bacterial Virulence Factors
G. Borlace (2008)
The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer.
P. Ernst (2000)
Mechanism and kinetics of the crosslinking reaction between biopolymers containing primary amine groups and genipin
M. Butler (2003)
Fucosylation and gastrointestinal cancer.
K. Moriwaki (2010)
Helicobacter pylori gastritis in cats with long-term natural infection as a model of human disease.
M. I. Esteves (2000)
Site-specific drug delivery of acetohydroxamic acid for the treatment of H. pylori
R. Umamaheswari (2003)
Helicobacter pylori virulence factors in gastric carcinogenesis.
S. Wen (2009)
Current understandings of Helicobacter pylori, peptic ulcer and gastroesophageal reflux disease.
Y. Liu (2006)
Development of pH-responsive chitosan/heparin nanoparticles for stomach-specific anti-Helicobacter pylori therapy.
Y. Lin (2009)
Contributions of genome sequencing to understanding the biology of Helicobacter pylori.
Z. Ge (1999)
Synthesis and characterization of gelatin nanoparticles using CDI/NHS as a non-toxic cross-linking system
Nader Taheri Qazvini (2011)
Helicobacter pylori colonization of the adenotonsillar tissue: fact or fiction?
S. Vilarinho (2010)
The treatment of Helicobacter pylori infection in the management of peptic ulcer disease.
J. H. Walsh (1995)
Helicobacter pylori infection and the risk of gastric carcinoma.
J. Parsonnet (1991)
Polyelectrolyte coated multilayered liposomes (nanocapsules) for the treatment of Helicobacter pylori infection.
P. Jain (2009)
Chemically modified chitin and chitosan as biomaterials
H. Sashiwa (2004)
Lectin-Gold Localization of Fucose Residues in Human Gastric Mucosa
J. Madrid (1998)
Helicobacter pylori Activates Myosin Light-Chain Kinase To Disrupt Claudin-4 and Claudin-5 and Increase Epithelial Permeability
J. Fedwick (2005)
Development of pHresponsive chitosan/heparin nanoparticles for stomach-specific anti-Helicobacter pylori therapy. Biomaterials 2009;30:3332e42
YH Lin (2009)
An in vitro adherence assay reveals that Helicobacter pylori exhibits cell lineage-specific tropism in the human gastric epithelium.
P. Falk (1993)
Helicobacter pylori and Gastric Cancer: Factors That Modulate Disease Risk
L. E. Wroblewski (2010)
The degradation pathways of glucagon in acidic solutions.
A. B. Joshi (2000)
Helicobacter pylori: the challenge in therapy
F. Bazzoli (2002)
Difference in expression of Helicobacter pylori gastritis in antrum and body.
E. Bayerdoerffer (1992)
Controlled release chitosan microspheres of mirtazapine: In vitro and in vivo evaluation
Om Ranjan (2011)
Detection of the intragastric sites at which Helicobacter pylori evades treatment with amoxycillin and cimetidine.
J. Atherton (1995)
cobacter pylori gastritis in cats with long - term natural infection as a model of human disease
MI Esteves (2000)
Gardenia jasminoides Ellis ethanol extract and its constituents reduce the risks of gastritis and reverse gastric lesions in rats.
Je-Hyuk Lee (2009)
The aggregation of pig articular chondrocyte and synthesis of extracellular matrix by a lactose-modified chitosan.
I. Donati (2005)
Gastric mucosal cell model for estimating relative gastrointestinal toxicity of non-steroidal anti-inflammatory drugs.
A. Hall (2006)
Novel pH-sensitive citrate cross-linked chitosan film for drug controlled release.
X. Shu (2001)
Hybrid polymer nanocapsules enhance in vitro delivery of azidothymidine-triphosphate to macrophages.
H. Hillaireau (2006)
Association of antibiotic resistance and higher internalization activity in resistant Helicobacter pylori isolates.
C. Lai (2006)
Design and characterization of antitumor drug paclitaxel-loaded chitosan nanoparticles by W/O emulsions.
J. Xu (2012)
An overview of pathogenesis and epidemiology of Helicobacter pylori infection
N. F. Tanih (2010)
A conductometric method for colloid titrations
K. Tǒei (1976)
Enzymic studies on the animal and intestinal bacterial metabolism of geniposide.
T. Akao (1994)
Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis.
S. J. Hessey (1990)
UNIDENTIFIED CURVED BACILLI IN THE STOMACH OF PATIENTS WITH GASTRITIS AND PEPTIC ULCERATION
B. Marshall (1984)
Membrane-associated, fucose-containing glycoproteins and glycolipids of cultured epithelial cells from human colonic adenocarcinoma and fetal intestine.
Y. S. Kim (1982)
Effect of genipin crosslinking on the optical spectral properties and structures of collagen hydrogels.
Yu-Jer Hwang (2011)
This paper is referenced by
Nanocarriers and Their Potential Application as Antimicrobial Drug Delivery
B. Devrim (2017)
Antibiotic treatment for Helicobacter pylori: Is the end coming?
S. Kim (2015)
An overview of nanotechnology-based treatment approaches against Helicobacter Pylori
T. Safarov (2019)
The potential utility of chitosan micro/nanoparticles in the treatment of gastric infection
I. Gonçalves (2014)
Development of genipin-crosslinked fucoidan/chitosan-N-arginine nanogels for preventing Helicobacter infection.
Y. Lin (2017)
Chitosan-based nanoparticles: An overview of biomedical applications and its preparation
Sweet Naskar (2019)
Chitosan Derivatives and Grafted Adjuncts with Unique Properties
H. Merzendorfer (2019)
Development of novel chitosan nanocomposites as a controlled drug release system for Helicobacter pylori treatment
Suna Seda Güneş (2016)
Ciprofloxacin loaded genipin cross-linked chitosan/heparin nanoparticles for drug delivery application
G. V. Kumar (2016)
Functionalized nanoparticles for targeting the gastrointestinal apical membrane receptors (Book Chapter)
F. Araújo (2016)
Current applications of nanoparticles in infectious diseases.
H. Zazo (2016)
Covalently and ionically, dually crosslinked chitosan nanoparticles block quorum sensing and affect bacterial cell growth on a cell-density dependent manner.
C. Vila-Sanjurjo (2020)
Dual drug-eluting stents coated with multilayers of hydrophobic heparin and sirolimus.
L. Su (2013)
Heparin-Based Nanoparticles: An Overview of Their Applications
M. Rodriguez-Torres (2018)
Genipin attenuates hyperoxia-induced lung injury and pulmonary hypertension via targeting glycogen synthase kinase-3 β in neonatal rats.
J. Li (2019)
Eradication of Helicobacter pylori: the power of nanosized formulations.
Q. Zhang (2020)
Polysaccharide-based nanoparticles by chitosan and gum arabic polyelectrolyte complexation as carriers for curcumin
Chen Tan (2016)
Real-time imaging tracking of a dual-fluorescent drug delivery system based on doxorubicin-loaded globin- polyethylenimine nanoparticles for visible tumor therapy.
Y. Zhang (2018)
SYNTHESIS OF CHITOSAN-BASED HYDROGEL BY USING PHOTOPOLYMERIZATION TECHNIQUE
N. Alemdar (2016)
Nutritional and additive uses of chitin and chitosan in the food industry
Carla Harkin (2019)
Bone cell responses to a low elastic modulus titanium alloy surface immobilized with the natural cross-linker genipin
Y. Sun (2018)
Cyclodextrin nanosystems in oral drug delivery: A mini review.
Oluwatomide Adeoye (2017)
Chitosan-based nanoparticles as drug delivery systems: a review on two decades of research
Sweet Naskar (2019)
Effect of the ultrastructure of chitosan nanoparticles in colloidal stability, quorum quenching and antibacterial activities.
C. Vila-Sanjurjo (2019)
Glycans in nanomedicine, impact and perspectives.
Susanna Sampaolesi (2019)
pH-responsive polymer-liposomes for intracellular drug delivery and tumor extracellular matrix switched-on targeted cancer therapy.
Yi-Ting Chiang (2014)
Carbohydrate-based nanocarriers and their application to target macrophages and deliver antimicrobial agents.
Tamim Mosaiab (2019)
Polymer Gels: Molecular Design and Practical Application
V. O. S. Neto (2018)
A novel gastroretentive porous microparticle for anti-Helicobacter pylori therapy: preparation, in vitro and in vivo evaluation.
S. Hao (2014)
Innovative Methods and Applications in Mucoadhesion Research.
A. Mackie (2017)
Active Targeted Nanoparticles for Oral Administration of Gastric Cancer Therapy.
Y. Lin (2015)
The Use of Nanoparticles for Antimicrobial Delivery
María Moreno-Sastre (2016)See more